JBS N.V.: Upside Confirmed, But Potentially Volatile For 2026E
seekingalpha.com
Want to monitor TNYA?
Get notified when price crosses targets, volume spikes, or RSI hits oversold
Create free account to monitor TNYAtenaya therapeutics is a privately-held biopharmaceutical company backed by the column group. the company was founded in 2016 by world-leading scientists from the gladstone institute’s cardiovascular division and the university of texas southwestern medical center. tenaya is dedicated to addressing heart failure through multipronged efforts that target the fundamental cellular pathologies present in diseased cardiac muscle and that leverage cutting-edge research in cardiac development and regeneration.